英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
Agios查看　Agios　在百度字典中的解释百度英翻中〔查看〕
Agios查看　Agios　在Google字典中的解释Google英翻中〔查看〕
Agios查看　Agios　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Agios
    Since our founding, Agios has been a pioneering leader in cellular metabolism, advancing therapies for patients with unmet needs Our mature and unique understanding of the science is foundational to our success and the connective thread that binds our people and our pipeline together
  • About Us - Agios
    Agios was founded in 2008 to unlock a new field of discovery in cellular metabolism This singular focus on metabolic disease has taken us from the development of precision therapies in oncology to pioneering new investigational medicines for the treatment of rare diseases
  • Agios Pharmaceuticals - Wikipedia
    Agios Pharmaceuticals Inc is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias [5]
  • Agios Pharmaceuticals, Inc. (AGIO)
    Find the latest Agios Pharmaceuticals, Inc (AGIO) stock quote, history, news and other vital information to help you with your stock trading and investing
  • Agios Pharmaceuticals - LinkedIn
    Fueled by Connections to Transform Rare Diseases™ | Agios is a commercial-stage biopharmaceutical company dedicated to redefining the future of rare disease treatment
  • Agios scraps blood cancer drug program after study setback
    Agios Pharmaceuticals said on Friday it will stop developing its experimental drug for a type of blood cancer after a mid-stage trial ‌failed to show enough benefit, marking a setback for the
  • Agios Pharmaceuticals (AGIO) Stock Could Be 22% Undervalued After RISE . . .
    Agios Pharmaceuticals (AGIO) stock is back in focus after the company shared detailed 52 week data from its RISE UP Phase 3 trial of mitapivat in sickle cell disease at EHA 2026 See our latest analysis for Agios Pharmaceuticals Agios Pharmaceuticals shares have recently picked up momentum, with a 7 day share price return of 10 25% and a 30 day share price return of 12 87% However, the 1
  • Agios Pharmaceuticals (AGIO) Is Up 5. 4% After Mixed 2025 Results And . . .
    Agios Pharmaceuticals has reported full-year 2025 results, with revenue rising to US$54 03 million from US$36 50 million a year earlier, while swinging from net income of US$673 73 million to a
  • Agios Pharmaceuticals (AGIO) News Today - MarketBeat
    What's going on at Agios Pharmaceuticals (NASDAQ:AGIO)? Read today's AGIO news from trusted media outlets at MarketBeat
  • Agios Pharmaceuticals Stock Suffers Record Wipeout As Wall . . . - Stocktwits
    Agios Pharmaceuticals, Inc shares crashed to their worst session on record on Wednesday after the company reported mixed late-stage trial results for its sickle cell disease treatment, triggering a wave of sharply lower analyst price targets





中文字典-英文字典  2005-2009